Technology Review profiles next-gen sequencing company Pacific Biosciences, which has raised $178 million to develop its zero mode waveguide technology. According to the article, the company's got 12 prototype instruments churning out data. And with read lengths targeting thousands of bases, PacBio has its eye on the medical market, where "we'll be able to detect rare mutations with unprecedented accuracy," says CTO Steve Turner.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.